HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japanese cosmetics pre-approval process likely to be abolished by March 2001.

This article was originally published in The Rose Sheet

Executive Summary

JAPANESE COSMETICS PRE-APPROVAL PROCESS LIKELY TO BE ABOLISHED BY March 2001 as international harmonization efforts continue, according to Japanese Cosmetics Industry Association Senior Managing Director Toru Arimoto. The JCIA exec told attendees of the European conference Global Cosmetic Regulatory Harmonization that he did not expect "any objection" from the Japanese government to end the current system. The U.S. Cosmetic, Toiletry and Fragrance Association and the European Cosmetic, Toiletry and Perfumery Association (COLIPA) have "strongly requested" the abolition of Japan's lengthy pre- approval and licensing system, he noted. The conference, sponsored by COLIPA and the Italian cosmetic trade association UNIPRO, was held in Florence, Italy, April 22-23.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005373

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel